Heated chemo drug tested for colon cancer safety
NCT ID NCT04761185
First seen Jan 09, 2026 · Last updated Apr 28, 2026 · Updated 16 times
Summary
This early-stage trial tested how well people with colorectal cancer tolerate a heated chemotherapy drug called raltitrexed given directly into the abdomen. The goal was to find a safe dose and check for side effects. 30 patients took part to help guide future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
Conditions
Explore the condition pages connected to this study.